Ajinomoto Bio-Pharma Services Revenue and Competitors
Estimated Revenue & Valuation
- Ajinomoto Bio-Pharma Services's estimated annual revenue is currently $146.8M per year.
- Ajinomoto Bio-Pharma Services's estimated revenue per employee is $155,000
Employee Data
- Ajinomoto Bio-Pharma Services has 947 Employees.
- Ajinomoto Bio-Pharma Services grew their employee count by 9% last year.
Ajinomoto Bio-Pharma Services's People
| Name | Title | Email/Phone |
|---|
Ajinomoto Bio-Pharma Services Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ajinomoto Bio-Pharma Services?
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client’s needs. Learn more: www.AjiBio-Pharma.com
keywords:N/A
N/A
Total Funding
947
Number of Employees
$146.8M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ajinomoto Bio-Pharma Services News
For biopharma executives engaging with CDMOs, rethinking domestic manufacturing goes beyond supply ... Q&A | Ajinomoto Bio-Pharma Services.
A detailed analysis of peptide contract manufacturing service providers' ... 13therapeutics; 9 Meters Biopharma; AAPPTec; Abbiotec; Abcepta...
WETTEREN, Belgium, March 30, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a manufacturing agreement expansion with AstraZeneca to include drug product manuf ...
TOKYO, Oct. 6, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the US FDA has approved the first commercial drug manufactured via Aji Bio-Pharma's proprie ...
WETTEREN, Belgium, Aug. 13, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a major expansion of small molecule manufacturing capabilities with the addition of ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $488.1M | 956 | 6% | N/A |
#2 | $191.6M | 957 | 27% | $50M |
#3 | $364M | 963 | -6% | N/A |
#4 | $242.9M | 964 | 6% | N/A |
#5 | $444.1M | 976 | -1% | N/A |